These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Comparing whole body 18F-2-deoxyglucose positron emission tomography and technetium-99m methylene diophosphate bone scan to detect bone metastases in patients with non-small cell lung cancer. Hsia TC; Shen YY; Yen RF; Kao CH; Changlai SP Neoplasma; 2002; 49(4):267-71. PubMed ID: 12382027 [TBL] [Abstract][Full Text] [Related]
4. Noninferiority of Dai D; Rollo FD; Bryant J; Kim EE Contrast Media Mol Imaging; 2018; 2018():8969714. PubMed ID: 29736155 [No Abstract] [Full Text] [Related]
5. A multicenter trial with a somatostatin analog (99m)Tc depreotide in the evaluation of solitary pulmonary nodules. Blum J; Handmaker H; Lister-James J; Rinne N Chest; 2000 May; 117(5):1232-8. PubMed ID: 10807805 [TBL] [Abstract][Full Text] [Related]
6. PET-FDG scan enhances but does not replace preoperative surgical staging in non-small cell lung carcinoma. Poncelet AJ; Lonneux M; Coche E; Weynand B; Noirhomme P; Eur J Cardiothorac Surg; 2001 Sep; 20(3):468-74; discussion 474-5. PubMed ID: 11509265 [TBL] [Abstract][Full Text] [Related]
7. Value of positron emission tomography for lung cancer staging. Albes JM; Dohmen BM; Schott U; Schülen E; Wehrmann M; Ziemer G Eur J Surg Oncol; 2002 Feb; 28(1):55-62. PubMed ID: 11869015 [TBL] [Abstract][Full Text] [Related]
8. The solitary pulmonary nodule--is it malignant or benign? Diagnostic performance of Tc-depreotide SPECT. Naalsund A; Maublant J Respiration; 2006; 73(5):634-41. PubMed ID: 16679755 [TBL] [Abstract][Full Text] [Related]
9. Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients. Kanzaki R; Higashiyama M; Maeda J; Okami J; Hosoki T; Hasegawa Y; Takami M; Kodama K Interact Cardiovasc Thorac Surg; 2010 Jun; 10(6):1009-14. PubMed ID: 20197344 [TBL] [Abstract][Full Text] [Related]
10. F-18-2-fluoro-2-deoxyglucose positron emission tomography compared to technetium-99m hexakis-2-methoxyisobutyl isonitrile single photon emission chest tomography in the diagnosis of indeterminate lung lesions. Santini M; Fiorelli A; Vicidomini G; Laperuta P; Busiello L; Rambaldi PF; Mansi L; Rotondo A Respiration; 2010; 80(6):524-33. PubMed ID: 20881375 [TBL] [Abstract][Full Text] [Related]
11. Mediastinal lymph node staging with FDG-PET scan in patients with potentially operable non-small cell lung cancer: a prospective analysis of 50 cases. Leuven Lung Cancer Group. Vansteenkiste JF; Stroobants SG; De Leyn PR; Dupont PJ; Verschakelen JA; Nackaerts KL; Mortelmans LA Chest; 1997 Dec; 112(6):1480-6. PubMed ID: 9404742 [TBL] [Abstract][Full Text] [Related]
12. 99mTc-depreotide scintigraphy versus 18F-FDG-PET in the diagnosis of radioiodine-negative thyroid cancer. Rodrigues M; Li S; Gabriel M; Heute D; Greifeneder M; Virgolini I J Clin Endocrinol Metab; 2006 Oct; 91(10):3997-4000. PubMed ID: 16895961 [TBL] [Abstract][Full Text] [Related]
13. Contribution of (99m)Tc-depreotide (Neospect) scintigraphy in lung cancer staging. Karathanos E; Datseris I; Vlontzou E; Zisimopoulos A; Georgiou E J BUON; 2010; 15(1):147-52. PubMed ID: 20414943 [TBL] [Abstract][Full Text] [Related]
14. Characterization of radiologically indeterminate lung lesions: 99mTc-depreotide SPECT versus 18F-FDG PET. Ferran N; Ricart Y; Lopez M; Martinez-Ballarin I; Roca M; Gámez C; Carrerea D; Guirao S; Leon AF; Martin-Comin J Nucl Med Commun; 2006 Jun; 27(6):507-14. PubMed ID: 16710105 [TBL] [Abstract][Full Text] [Related]